The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Bioprosthetic valve dysfunction and reoperations/reinterventions are common after aortic valve replacement (AVR) with bioprosthetic valves, leading to cycles of left ...

Background: Following transcatheter aortic valve replacement, acute coronary obstruction is ... coronary artery ostium to prevent coronary artery obstruction. The BASILICA (Bioprosthetic or Native ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...

Perspective from Gilbert H.L. Tang, MD, MSc, MBA CHICAGO — The first trial to evaluate use of an SGLT2 inhibitor in people undergoing transcatheter aortic valve replacement showed benefit with ...

Patients enrolled at 28 U.S. sites between 2018 and 2024 with moderate-to-severe or severe symptomatic aortic regurgitation underwent TAVR with the JenaValve Trilogy transcatheter heart valve. Total ...

bicuspid aortic valve, and sporadic TAA. Online databases were searched for studies that reported aortic growth on adult patients with asymptomatic TAA. Pooled GRs were calculated for 3 different TAA ...

The procedure that delivers a bioprosthetic device through flexible tube to a patient’s failing aortic valve didn’t originally have a name when it debuted more than 20 yours ago. Now—to the chagrin of ...